Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-24-023150

Options or other derivatives

  • Director acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Martell Robert Director 2024-06-06 Grant or award · Stock Option (right to buy) +12,500 12,500 D: show line 1 in the form
Loading xslF345X05/ownership.xml…